Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Curaleaf Holdings Inc.

Healthcare CA CURA

3.08CAD
0.02(0.65%)

Last update at 2026-03-10T20:00:00Z

Day Range

3.033.14
LowHigh

52 Week Range

0.996.97
LowHigh

Fundamentals

  • Previous Close 3.06
  • Market Cap2421.91M
  • Volume565929
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA229.30M
  • Revenue TTM1275.83M
  • Revenue Per Share TTM1.69
  • Gross Profit TTM 624.83M
  • Diluted EPS TTM-0.49

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -117.62900M -167.85517M -112.59470M -77.97841M 41.31M
Minority interest - - - - -
Net income -215.42300M -379.52792M -481.81467M -258.19370M -76.67011M
Selling general administrative 398.74M 392.79M 408.15M 373.90M 234.88M
Selling and marketing expenses 48.48M 41.99M 39.75M 41.84M 23.27M
Gross profit 639.25M 644.70M 667.70M 607.67M 142.15M
Reconciled depreciation - - - - -
Ebit -17.01300M 57.88M 84.60M 73.43M -204.10982M
Ebitda 233.14M 343.90M 300.25M 240.89M -97.19068M
Depreciation and amortization 250.16M 286.02M 215.64M 167.45M 106.92M
Non operating income net other - - - - -
Operating income 20.20M 57.88M 84.60M 73.43M -204.10982M
Other operating expenses 1322.61M 1759.65M 1575.81M 1426.01M 1044.62M
Interest expense 100.62M 100.38M 88.84M 90.26M 69.00M
Tax provision 98.59M - - - -
Interest income 93.22M - - - -
Net interest income - - - - -
Extraordinary items -5.78600M - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 98.59M 154.66M 232.80M 191.13M 117.43M
Total revenue 1342.80M 1817.53M 1660.41M 1499.45M 840.51M
Total operating expenses 619.05M 586.82M 583.10M 534.24M 346.26M
Cost of revenue 703.55M 1172.83M 992.71M 891.78M 698.36M
Total other income expense net -137.82600M -225.73380M -197.19955M -151.41329M 245.42M
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares -215.42300M - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 2949.54M 4083.15M 4626.56M 3922.17M 3013.65M
Intangible assets 1085.40M 1172.44M 1213.30M 1010.01M 707.63M
Earning assets - - - - -
Other current assets 7.19M 63.55M 283.57M 147.04M 87.45M
Total liab 2088.32M 2538.68M 2728.52M 1818.91M 1255.77M
Total stockholder equity 861.21M 1385.38M 1733.94M 1952.98M 1756.46M
Deferred long term liab - - - - -
Other current liab - 452.51M 451.79M 160.26M 90.74M
Common stock 2237.47M - - 2811.70M 2235.12M
Capital stock - - - - -
Retained earnings -1356.17400M -1504.19427M -1164.65269M -618.25887M -242.15045M
Other liab - - - - -
Good will 628.88M 826.27M 847.02M 765.26M 686.46M
Other assets 0.40M 0.00000M 0.00000M - -
Cash - 121.07M 221.10M 378.10M 93.69M
Cash and equivalents 107.23M - - - -
Total current liabilities 387.93M 651.43M 673.23M 399.46M 280.44M
Current deferred revenue - 1.14M 0.92M 175.80M 101.47M
Net debt - 1327.04M 1333.85M 645.22M 642.30M
Short term debt 0.00000M 93.19M 111.06M 29.62M 28.30M
Short long term debt - - - - -
Short long term debt total - 1448.11M 1554.95M 1023.32M 736.00M
Other stockholder equity -20.08000M 2905.23M 2923.78M 76.55M -6.63499M
Property plant equipment 768.11M - - - -
Total current assets 429.68M 551.97M 884.00M 917.83M 532.36M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - - - - -
Net receivables 61.27M 82.65M 61.22M 79.25M 40.10M
Long term debt 466.90M - - - -
Inventory 220.65M 284.70M 318.12M 313.45M 311.11M
Accounts payable - 104.59M 109.47M 33.79M 59.93M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -15.65837M -25.19394M -317.00644M -229.87801M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 589.76M 673.50M 489.09M 554.76M
Deferred long term asset charges - - - - -
Non current assets total - 3531.18M 3742.55M 3004.34M 2481.30M
Capital lease obligations - - - - -
Long term debt total 819.27M - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities -93.82900M - - - -
Net borrowings - - - - -
Total cash from financing activities -54.23800M -96.07477M 54.41M 457.79M 300.55M
Change to operating activities - - - - -
Net income -216.22100M -310.17831M -336.49918M -258.19370M -76.67011M
Change in cash 15.41M -100.02546M -157.00075M 284.40M 38.83M
Begin period cash flow 91.82M 221.10M 378.10M 93.69M 54.87M
End period cash flow 107.23M 121.07M 221.10M 378.10M 93.69M
Total cash from operating activities 162.57M 101.58M 60.41M -73.06754M 16.57M
Issuance of capital stock - - - - -
Depreciation 250.16M 286.02M 215.64M 167.45M 106.92M
Other cashflows from investing activities -3.75600M - - - -
Dividends paid - - - - -
Change to inventory 2.99M 13.30M -20.96375M -116.75134M -123.91477M
Change to account receivables 2.21M 0.15M -26.32348M -31.66552M 7.99M
Sale purchase of stock 0.16M - - - -2.50800M
Other cashflows from financing activities -11.69400M -42.30594M -19.65538M -6.25236M 53.60M
Change to netincome - - - - -
Capital expenditures 98.15M 94.89M 175.29M 215.59M 169.37M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 103.69M 46.08M 85.98M -69.94950M 38.35M
Stock based compensation 25.70M 20.01M 28.02M 39.48M 29.36M
Other non cash items 53.91M 675.60M 528.33M 597.15M 248.67M
Free cash flow 64.42M 6.69M -114.87555M -288.65313M -152.79835M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CURA
Curaleaf Holdings Inc.		 0.02 0.65% 3.08 - 138.89 1.90 2.05 1.88 11.75
BHC
Bausch Health Companies Inc		 0.08 1.10% 7.33 5.94 1.34 0.29 18.74 2.18 6.64
CRON
Cronos Group Inc		 0.01 0.29% 3.44 23.40 32.26 10.16 0.92 1.27 -1.9458
TLRY
Tilray Inc		 -0.14 1.40% 9.83 - 1000.00 1.34 0.56 1.09 -2.299
WEED
Canopy Growth Corp		 -0.02 1.37% 1.44 - 20.49 2.32 0.83 2.04 -1.5049

Reports Covered

Stock Research & News

View All

Profile

Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of hemp-derived THC products through wholesale channels. The company is headquartered in Stamford, Connecticut.

Curaleaf Holdings Inc.

290 Harbor Drive, Stamford, CT, United States, 06902

Key Executives

Name Title Year Born
Mr. Boris Alexis Jordan CEO & Chairman 1966
Mr. Joseph F. Lusardi Executive Vice-Chairman 1975
Mr. Edward Kremer Chief Financial Officer 1972
Mr. Peter Laurence Clateman J.D. Chief Legal Officer 1968
Mr. Matthew S. Darin Special Advisor NA
Mr. Camilo Russi Lyon Chief Investment Officer NA
Ms. Christine Taylor Chief Accounting Officer NA
Mr. Jakob Feinstein Manager of Investor Relations NA
Mr. James S. Shorris Chief Compliance Officer 1961
Ms. Kate Lynch Executive Vice President of Marketing NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.